HomeDMAAU • NASDAQ
add
Drugs Made In America Acquisition Units
Previous close
$10.49
Year range
$10.00 - $10.70
Market cap
347.24M USD
Avg Volume
594.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 263.70K | 81.95% |
Net income | 2.18M | 1,607.34% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 717.00 | -65.78% |
Total assets | 237.63M | 55,664.06% |
Total liabilities | 244.96M | 41,348.68% |
Total equity | -7.33M | — |
Shares outstanding | 33.52M | — |
Price to book | -47.68 | — |
Return on assets | -0.28% | — |
Return on capital | 9.11% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 2.18M | 1,607.34% |
Cash from operations | -56.11K | — |
Cash from investing | 0.00 | — |
Cash from financing | 56.00K | — |
Net change in cash | -105.00 | — |
Free cash flow | 11.78K | — |
About
Founded
2024
Website
